1. Home
  2. ASTL vs ASMB Comparison

ASTL vs ASMB Comparison

Compare ASTL & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Algoma Steel Group Inc.

ASTL

Algoma Steel Group Inc.

HOLD

Current Price

$3.39

Market Cap

467.0M

Sector

Industrials

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$28.08

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTL
ASMB
Founded
1902
2005
Country
Canada
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
467.0M
440.0M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
ASTL
ASMB
Price
$3.39
$28.08
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$43.40
AVG Volume (30 Days)
1.4M
94.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.71%
N/A
EPS Growth
N/A
50.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$33.33
Revenue Next Year
$33.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.02
$7.76
52 Week High
$7.25
$39.71

Technical Indicators

Market Signals
Indicator
ASTL
ASMB
Relative Strength Index (RSI) 29.96 46.78
Support Level $3.09 $26.50
Resistance Level $4.77 $30.66
Average True Range (ATR) 0.28 1.42
MACD -0.13 -0.03
Stochastic Oscillator 0.69 27.35

Price Performance

Historical Comparison
ASTL
ASMB

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: